Effects of long-term administration of lithium and hydrochlorothiazide in rats

Metal-Based Drugs

Volumn 6, Issue 2, 1999, Pages 87-93

  Loghin, Felicia ^a   Olinic, Adriana ^a   Popa, Daniela Saveta ^a   Socaciu, Carmen ^a   Leucuta, Sorin E ^a  

^a IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALI METAL; ALKALINE PHOSPHATASE; AMINOTRANSFERASE; CHOLINESTERASE; HYDROCHLOROTHIAZIDE; LITHIUM; THIAZIDE DIURETIC AGENT;

ALKALINE PHOSPHATASE BLOOD LEVEL; AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN; CHOLINESTERASE BLOOD LEVEL; CONTROLLED STUDY; HISTOPATHOLOGY; KIDNEY; LIVER; LIVER TOXICITY; LONG TERM CARE; MALE; NEPHROTOXICITY; NONHUMAN; ORAL DRUG ADMINISTRATION; RAT; SPLEEN;

EID: 0032773989     PISSN: 07930291     EISSN: None     Source Type: Journal    
DOI: 10.1155/MBD.1999.87     Document Type: Article

References (18)

1. Hollister L.E., Csernansky J.G.. Clinical Pharmacology and Psychotherapeutic Drugs, Churchill-Livingstone Inc. New York (1990) : 132-133
2. Georgotas A., Cancro R.. Depression and Mania, Elsevier New York (1988) : 345-349
3. Austin M.P.V., Souza F.G., Goodwin G.M.. Lithium Augmentation in Antidepressant-Resistant Patients, Br.J.Psychiatry (1991) 159 : 510-514
4. Cazabat S.. Chez un patient sous lithium il faut se mefier constamment des interactions medicamenteuses, Le Quotidien du medecin (1993) 12 : 13-14
5. Ciraulo D.A., Shader R.I., Greenblatt D.J., Creelman W.. Drug Interactions in Psychiatry, Williams & Wilkins Baltimore (1987) : 127-151
6. Johnson F.N. Lithium Combination Treatment, Karger Basel (1987) : 246-260
7. Ragheb M.. The Clinical Significance of Lithium-Nonsteroidal Anti-inflammatory Drug Interactions, J.Clin.Psychopharmacol. (1990) 10(5) : 350-354
8. Himmelhoch J.M., Poust R.I., Mallinger A.G., Hanin I., Neil J.F.. Adjustment of lithium dose during lithium-chlorothiazide therapy, Clin.Pharmacol.Ther. (1977) 22(2) : 225-227
9. Young L.Y., Koda Kimble M.-A.. Applied Therapeutics. The Clinical Use of Drugs, Applied Therapeutics Inc. Washington (1988) : 1256-1263
10. Hayes W.A.. Principles and Methods of Toxicology, Raven Press New York (1982) : 413
11. Mitrica N.. Laboratorul Clinic. Biochimie, Ed.Medicala Bucuresti (1981): 283-300
12. Klemfuss H., Bauer T.T., Greene K.E., Kripke D.F.. Dietary calcium blocks lithium toxicity in hamsters without affecting circadian rhythms, Biol.Psychiatry (1992) 31(3): 315-321
13. Viegut V., Jefferson J.W.. Lithium and the Liver, Liver (1990) 1:9-13
14. Toader S., Kory M., Rotaru O., Pop R.D., Bohm B., Leucuta S.E.. Clinical Aspects and Histopathological Changes of Some Organs in the Intoxication Following Repeated Doses of Lithium Administered Intraperitoneally to Rats, Proceeding of 4 Spurenelement Symposium. Lithium. Jena (1983) : 300-305
15. Olinic A., Pantea A., Coca M., Onisor I., Anca Z., Kovats A.. Kidney, liver and thyroid changes in rats under the effect of long-term lithium excess, Clujul Medical (1994) 67(3-4): 225-231
16. Marsussen N., Christensen S., Petersen J.S., Shalmi M.. Atubular glomeruli, renal function and hypertrophic response in rats with chronic lithium nephropathy, Virchows Archiv A . Pathol.Anat. (1991) 419: 281-289
17. Fritz H. Lithium and the Developing Rat Kidney in Transplacental Target Organ Toxicity, Arzneim.Forsch./ Drug Res. (1988) 38(1):50-54
18. Loghin F., Leucuta S.E.. Pharmacokinetic interactions of lithium with thiazide diuretics in rats, Farmacia (1994) 42 (5-6): 13-16